Filing Flows › Stryker (SYK) › Q3 2026
Stryker (SYK) Q3 2026 earnings results (third quarter 2026)
10-Q filed Oct 30, 2026
Stryker (SYK) reported revenue of $6.5B for the third quarter 2026 (Q3 2026), +8% from a year earlier and -1% from the quarter before. Operating margin was 15.9%, net earnings $753M (11.5% of revenue).
Stryker, Q3 2026: revenue $6.5B (+8% year over year), operating margin 15.9%, net earnings $753M, operating cash flow $1.5B. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $6.5B | -1% | +8% |
| Gross profit | $4.2B | -6% | +10% |
| Operating profit | $1.0B | -38% | -9% |
| Net earnings | $753M | -41% | -12% |
| Operating cash flow | $1.5B | +16% | -5% |
| Free cash flow | $1.2B | +16% | -10% |
What changed
Revenue was $6.5B in Q3 2026, up 8% year over year and down 1% from the previous quarter. MedSurg and Neurotechnology: was the largest line at 56% of revenue. MedSurg and Neurotechnology: added $0.31B year over year (up 9%), 67% of the total change.
Gross margin was 65.2%, up 1.6 points from Q3 2025. Operating profit was $1.0B, a 15.9% margin (down 2.9 points year over year). Operating profit fell $0.10B even though revenue rose $0.46B versus Q3 2025, so costs grew faster than sales. Operating expenses grew 18% against revenue growth of 8%. The fastest-growing cost line was Other operating costs (+79%). Net earnings were $0.75B, down 12% year over year. The effective tax rate was 24.5%.
Operating cash flow was $1.5B (down 5% year over year), 194% of net earnings. Non-cash charges added back $0.40B of depreciation and amortization and $0.07B of share-based compensation. Working capital and other items added $0.24B. Capital expenditures of $0.24B left free cash flow of $1.2B.
Questions
What was Stryker's revenue in the third quarter 2026?
Stryker (SYK) reported revenue of $6.5B for the third quarter 2026 (Q3 2026), +8% from a year earlier and -1% from the quarter before.
Was Stryker profitable in the third quarter 2026?
Operating profit was $1.0B (15.9% of revenue) and net earnings $753M.
Source: Stryker 10-Q on SEC EDGAR.